Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)
暂无分享，去创建一个
R. Schlenk | A. Ganser | K. Götze | M. Lübbert | U. Germing | R. Haas | A. Giagounidis | U. Platzbecker | N. Gattermann | G. Büsche | F. Nolte | A. Letsch | P. Schafhausen | G. Bug | U. Bacher | K. Shirneshan | M. Wulfert | D. Haase | F. Braulke | E. Schuler